UTAH MEDICAL PRODUCTS INC (UTMD) Stock Institutional Trading Activity


UTAH MEDICAL PRODUCTS INC (UTMD) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Renaissance Technologies LLC, Sequoia Financial Advisors, and Bares Capital Management. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q3 2018Renaissance Technologies LLCBuy31,661250,583$23,605
Q1 2018Renaissance Technologies LLCBuy6,722218,922$21,640
Q4 2017Renaissance Technologies LLCBuy18,900212,200$17,273
Q3 2017Renaissance Technologies LLCBuy26,755193,300$14,217
Q2 2017Renaissance Technologies LLCBuy21,845166,545$12,058
Q1 2017Renaissance Technologies LLCBuy7,700144,700$9,015
Q4 2016Renaissance Technologies LLCBuy2,000137,000$9,967
Q3 2016Renaissance Technologies LLCBuy4,500135,000$8,073
Q2 2016Renaissance Technologies LLCBuy6,769130,500$8,222
Q1 2016Renaissance Technologies LLCBuy14,731123,731$7,738
Q4 2015Renaissance Technologies LLCBuy14,200109,000$6,381
Q3 2015Renaissance Technologies LLCBuy2,40094,800$5,107
Q2 2015Renaissance Technologies LLCBuy2,40092,400$5,510
Q1 2015Renaissance Technologies LLCBuy1,30090,000$5,387
Q4 2014Renaissance Technologies LLCBuy1,00088,700$5,326
Q3 2014Renaissance Technologies LLCBuy40087,700$4,276
Q2 2014Bares Capital ManagementSell-88,249303,667$15,621
Q2 2014Renaissance Technologies LLCBuy7,00087,300$4,491
Q1 2014Bares Capital ManagementSell-7,021391,916$22,665
Q1 2014Renaissance Technologies LLCBuy4,90080,300$4,644
Q4 2013Bares Capital ManagementSell-22,905398,937$22,803
Q4 2013Renaissance Technologies LLCBuy7,30075,400$4,310
Q3 2013Bares Capital ManagementSell-573421,842$25,068
Q3 2013Renaissance Technologies LLCBuy13,40068,100$4,048
Q2 2013Bares Capital ManagementBuy422,415422,415$22,937
Q2 2013Renaissance Technologies LLCBuy54,70054,700$2,970

Frequently asked questions about UTMD activity

  • Which institutional owners are buying UTMD?

    Institutional owners buying UTMD include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in UTMD activity?

    "Buy" means an investor increased their reported position in UTMD compared to the prior reporting period. This reflects growing exposure to UTAH MEDICAL PRODUCTS INC (UTMD) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in UTMD increasing?

    Institutional interest in UTMD can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.